India: 13 quality stocks, wildly different prices

2026-09-25 · By Lubin Danilo, founder of Lubin Investment

Analyze a stock on Lubin Investment

My financial quality screener flagged thirteen Indian companies that pass nearly all of my criteria, from electric scooters to a commodities exchange. Nine still trade at a fair or discounted price, but four are already pricier than what my model justifies. The full breakdown, company by company.

Thirteen near-perfect companies, in a country almost nobody covers

India is the world's fifth largest economy by GDP and lists more publicly traded companies than any other major emerging market. Yet in everything I usually cover on this site, it barely registers. French and European investors who venture there tend to know two or three names from the financial press, Reliance, Infosys, maybe Tata Motors, and stop there.

I wanted to see what my financial quality screener, the one that grades every stock my site tracks on ten concrete criteria (profitability, sales and cash growth, real share buybacks, margins, manageable debt), actually finds on this market once you look past the usual three names. The result: thirteen Indian companies pass at least nine of my ten criteria, eleven of them all ten.

This is not a hand-picked list built to tell a nice story. It is the raw output of my model applied without regard to size or sector, from a two-wheeler manufacturer worth close to twelve billion dollars down to an auto parts supplier worth barely thirty-nine million. The common thread is neither sector nor size: it is financial soundness as my model measures it.

The full table: thirteen sectors, one filter

Before the table, a quick reminder of what I measure. P/FCF (price-to-free-cash-flow) divides the share price by free cash flow, the money that actually stays in the company's coffers once every bill is paid. A P/FCF of 4 means you are paying today for four years of that cash. The lower it is, the cheaper each dollar of cash produced. The last column compares today's price to the fair buy price my model computes for each company: a positive number signals a discount, a negative one means the stock is already pricier than what I would consider paying.

Nine of the thirteen still trade at a price my model considers fair or discounted. Four are already pricier than that computed fair buy price. The quality score says strictly nothing about this second column: it measures how sound the business is, never whether today's price is the right moment to buy. That is exactly why I always keep the two questions separate.

The steepest discounts, and why they need a careful read

Anand Rathi Share and Stock Brokers and BF Utilities each trade at more than double my fair buy price, the steepest discounts of the group. What the two share: both run businesses that tie up very little capital. Anand Rathi is a brokerage, and its return on capital actually employed (my cash ROCE metric) reaches 52.9%, typical of a fee-based business rather than a factory. BF Utilities is essentially a holding company: it owns stakes in wind farms and a toll road concession rather than directly running a single industrial operation.

That structure partly explains such an extreme discount. A holding company almost always trades below the sum of what it owns: the market applies a holding discount, because a minority shareholder never directly controls the underlying assets. A 216% discount is not necessarily an anomaly waiting to close, it is partly a structural feature of the vehicle itself. I flag this honestly rather than sell a spectacular number without the nuance.

Omax Autos, discounted 110.3%, is a different case: a conventional auto parts supplier, but with a market cap of roughly $39 million, making it a genuine micro-cap. At that size, the free float is thin, the gap between bid and ask can be wide, and a handful of sellers can move the price by several percent. The price on paper can be right while practical access to it is much less so.

The cases that read most simply: quality already priced fairly

Hero MotoCorp, the world's largest two-wheeler manufacturer, trades almost exactly at my fair buy price (only a 1.3% discount). Its return on capital employed is high (cash ROCE of 30.6%) and its net debt amounts to barely a few weeks of annual free cash flow, next to nothing. One fact behind the market's current confidence: its electric brand Vida, launched in 2023 with barely 1% of India's electric two-wheeler market, crossed an 11% market share in June 2026, with monthly registrations up 176% year over year, according to figures reported by Whalesbook. The company is doubling production capacity to keep up, from 330,000 to 660,000 units a year by 2027.

Multi Commodity Exchange (MCX), the country's leading commodities exchange, carries a residual 5.3% discount and an unusually high return on capital employed (83.4%), typical of a market infrastructure business that needs very little capital to run. Its revenue jumped 67.9% year over year: average daily futures turnover rose from 27,153 to 64,407 crore rupees between fiscal 2025 and 2026, and options notional turnover from 191,909 to 471,641 crore, with 2.09 million clients active in derivatives, according to India Infoline. One honest caveat: the free cash flow margin my model computes for MCX exceeds 100% of revenue, an unusual ratio I cannot confidently explain from public data alone (likely related to how an exchange books treasury income from its settlement guarantee fund separately from operating revenue), so I flag it rather than invent a mechanism I have not verified.

BLS International, which outsources visa processing for foreign governments, trades close to fair value (a 2.7% discount). The company signed a February 2026 contract with the Embassy of Cyprus to handle visa applications in China, Mongolia, Cambodia and Laos, renewed its Spain contract to include national visas for the first time, and signed an exclusive Slovakia contract covering eighteen countries, according to the company's announcements. Management is guiding for 20 to 25% growth driven by these new contracts.

The traps: when quality is already fully priced in

Anthem Biosciences is the clearest case. This pharma CDMO (contract development and manufacturing organization, a company that manufactures drugs on behalf of labs that would rather outsource production than build their own plants) listed in July 2025 at 570 rupees a share, a 3,395 crore rupee offering (about $397 million) made entirely of shares sold by existing holders, with no new shares issued. Demand was strong from day one, 73% subscribed. The stock now trades around 875 rupees, over 50% above its IPO price, and my model considers it 52.6% pricier than what I would pay.

CarTrade Tech, the online auto marketplace, carries a 9 out of 10 quality score but is overpriced by 43.1%. Hindustan Copper, one of the country's few copper producers and majority owned by the Indian state, trades 23.7% above my fair buy price: near-monopoly status supplying a metal strategic for the energy transition tends to command a scarcity premium regardless of what its cash flows alone would justify.

KPIT Technologies is the subtlest of the four. Its P/FCF of 14.4x looks reasonable by software standards, and the business is genuinely real: the company signed deals worth $349 million in the last quarter of its fiscal 2026, including a partnership worth over $50 million with a global off-highway equipment maker and an agreement with a leading Japanese Tier 1 supplier on next-generation digital cockpits, then announced in May 2026 the acquisition of a majority stake in Israeli automotive cybersecurity firm Cymotive, according to KPIT's official release. But a modest P/FCF does not automatically mean undervalued: my model already bakes in a growth trajectory, and on that basis KPIT still sits 20.1% above my fair buy price. A low ratio can remain a poor entry point if the growth it assumes is already priced in.

Risks the table alone does not show

The first is currency risk. The Indian rupee trades today around 96 to the dollar and has lost 8.2% of its value against it over the past twelve months. An apparent discount on paper can therefore be partly or entirely erased by the local currency's depreciation before you sell the position. I cover this mechanism in more depth in my article on a company's listing currency, useful for any market outside the eurozone or dollar.

The second is a governance risk more diffuse than what I already documented for South Korea, but real nonetheless: a good share of listed Indian companies, including some on this list, remain majority controlled by a founding family or, in Hindustan Copper's case, by the Indian state itself. The float genuinely available to a minority shareholder can be thinner than total market cap suggests, and governance standards are not uniformly aligned with what a developed market requires.

The third is practical: none of these thirteen stocks is eligible for a French PEA tax-advantaged account. You need a standard brokerage account with access to the Indian market, currency conversion fees, and for the smallest names like Omax Autos, meaningfully lower liquidity than a standard US or European stock.

How I use this, and what I do not do

On my site, I always judge a company's quality separately from its price: a great company bought too expensively is still a bad investment, a mediocre one on sale is still mediocre. This list of thirteen names shows it clearly: the same near-perfect quality score coexists with completely opposite pricing situations, from a discount of more than double down to a premium of over half. I never turn a spectacular discount into an automatic buy signal without understanding where it comes from, a holding structure, a micro-cap, or simply a market that has not noticed the company yet.

I already covered India's two largest listed banks on my site in my analysis of Indian banks ICICI and Kotak: the thirteen companies listed here add to that without overlapping either name. You can check each individual page, for instance Hero MotoCorp, MCX or Anthem Biosciences, and find my full rating methodology on the methodology page.

• 13 Indian companies pass at least 9 of my 10 financial quality criteria, across every sector and every size.
• 9 still trade at a fair or discounted price under my model, Anand Rathi and BF Utilities showing the steepest discounts (more than double my fair buy price), partly due to their holding company structure.
• 4 are already pricier than what my model justifies, Anthem Biosciences leading (52.6% above my fair buy price), a year after its IPO.
• The rupee has lost 8.2% against the dollar over twelve months: a real currency risk to add to any apparent discount.
• Quality and price remain two separate questions, even in a market this lightly covered by European investors.

FAQ

What is P/FCF, and how do I use it for this ranking?

P/FCF (price-to-free-cash-flow) divides the share price by annual free cash flow, the money actually left over once every bill is paid. A P/FCF of 4 means you are paying for four years of that cash. I always compare it to my model's computed fair buy price rather than looking at the raw number alone.

Are all these Indian stocks cheap?

No. Nine of the thirteen trade at a price my model considers fair or discounted, but four (Anthem Biosciences, CarTrade Tech, Hindustan Copper, KPIT Technologies) are already pricier than my computed fair buy price, despite a near-perfect quality score.

Can I hold Indian stocks in a French PEA?

No. Stocks listed in India are not eligible for the French PEA tax-advantaged account. You need a standard brokerage account with access to the Indian market, currency conversion fees, and sometimes lower liquidity, especially on smaller names like Omax Autos.

Why do Anand Rathi and BF Utilities show such an extreme discount?

Both are low capital-intensity structures: Anand Rathi is a fee-based brokerage, BF Utilities is mostly a holding company owning stakes in wind farms and a toll road concession. The market almost always applies a discount to holding companies, because a minority shareholder never directly controls the underlying assets: this is not necessarily an anomaly that will close.

Does a 9 or 10 out of 10 quality score mean I should buy right away?

No. My quality score only judges how financially sound a company is, never whether today's price is the right moment to buy. That is exactly why 4 of the 13 companies on this list, despite a near-perfect score, are already pricier than my fair buy price.

Related reading

• Indonesia: 4 quality stocks, only one overpriced
• South Korea: 5 quality stocks the discount still hits
• Hero MotoCorp: the world's top two wheeler maker

Analyze a stock on Lubin Investment

About the author

Written by Lubin Danilo, founder of Lubin Investment. A self-taught individual investor, I find fundamental analysis fascinating, and it has delivered excellent results. For three years now, my performance has beaten the S&P 500. But analyzing every stock took too much time: sites with incomplete data, calculation methods and criteria never aligned with mine. And spotting the best stocks was just as time-consuming, even with my own well-defined checklist. So I put my software development background to work to build this software, base my investment strategy on its results, and share it with people who share the same passion as me. It judges a company's quality and its price separately, using criteria drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran).